Chest Meeting
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


COPYRIGHT © 2005 by the American College of Chest Physicians.
This Article
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zanen, P.
Right arrow Articles by Lammmers, J.-W. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Zanen, P.
Right arrow Articles by Lammmers, J.-W. J.

Assessing Function in COPD


Monday, October 31, 2005

10:30 AM - 12:00 PM

PREVALENCE OF HYPERINFLATION IN COPD AND CORRELATION WITH FLOW-VOLUME INDICES

Pieter Zanen, PhD*, Frans Rutten, MD, Arno W. Hoes, PhD and Jan-Willem J. Lammmers, RRT

UMCU, Utrecht, Netherlands

PURPOSE: Identification of hyperinflation in COPD is important, because it causes dyspnea and limitation of exercise, and it is a predictor of mortality. Detection of hyperinflation in primary care, however, is difficult because only hand-held spirometers are used.

METHODS: 441 patients, classified as COPD by their general practitioner, visited our out-patient clinic for further pulmonary investigations. Diagnosis of COPD was based on the GOLD criteria (postbronchodilator FEV1/FVC <0.70). The RV/TLC ratio was used to chart hyperinflation, and a value ≥1.64 SD from the predicted value was used to indicate hyperinflation. Prevalence of hyperinflation, and correlation with pre-bronchodilator spirometry indices were calculated. The latter was done to assess whether spirometry indices could be used as surrogate marker of hyperinflation.

RESULTS: In COPD patients with GOLD stage 0, 13% of the subjects showed hyperinflation. 22.4% of the patients in GOLD stage 1 were hyperinflated, in GOLD stage 2 55.1%, and patients in GOLD stage 3 87.2%. Non-parametric correlation showed that of the spirometry indices, FEV1 (as percent of predicted) correlated best with RV/TLC ratio (r= -0.682; p<0.001). Second and third best were the MEF75 and PEF with r = -0.656, and r= -0.649 (both p<0.001). The FEV1-reversibility had a low correlation (r= 0.217; p<0.001).Linear regression showed that with each percent of FEV1 lost, the RV/TLC ratio increased by 0.044 SD points. The optimal cut off value for the baseline FEV1 ap-peared to be 70% of the predicted value (<70% indicates hyperinflation). Receiver Op-erating Characteristics (ROC) curve analysis showed that a high FEV1 correctly diag-nosed an absence of hyperinflation in 85.6% of all cases. The sensitivity/specificity of excluding hyperinflation at this 70% cut off level was 78.0% and 76.7%.

CONCLUSION: Hyperinflation is often present in COPD and when FEV1 <70% of predicted hyperinflation is very probable.

CLINICAL IMPLICATIONS: FEV1 may be used as a surrogate marker for detect hyperinflation when helium dilution and/or bodyplethysmography are unavailable.

DISCLOSURE: Pieter Zanen, None.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American College of Chest Physicians.